Policy & Regulation
Asymchem welcomes Scott A. May to BSA
14 March 2019 -

API pharmaceutical company Asymchem revealed on Wednesday the addition of Scott A. May to its board of scientific advisers (BSA).

The company added Dr May joins Professors Barry Sharpless, Phil Baran, Stephen Buchwald and other members on the advisory board.

Established in June 2013, the BSA consists of 11 academic and industry technical leaders to provide valuable advice on research targets as well up-to-date technologies with potential applications into the CDMO space. Collaborative research opportunities have continued to yield publications in JOC, JACS, OPRD, Science and others.

Previously, Dr May was a senior organic chemist of Process Research group at Eli Lilly and the research fellow in the Small Molecule Design and Development group.